In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, OnKure Therapeutics Inc (NASDAQ: OKUR) closed at $1.84 down -5.64% from its previous closing price of $1.95. In other words, the price has decreased by -$5.64 from its previous closing price. On the day, 0.76 million shares were traded.
Ratios:
For a deeper understanding of OnKure Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.17 and its Current Ratio is at 11.17. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 05, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $33.
On October 10, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $35.Oppenheimer initiated its Outperform rating on October 10, 2024, with a $35 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 07 ’25 when Saccomano Nicholas A sold 516 shares for $2.67 per share. The transaction valued at 1,378 led to the insider holds 3,682 shares of the business.
Saccomano Nicholas A sold 358 shares of OKUR for $1,191 on Apr 04 ’25. The President and CEO now owns 4,198 shares after completing the transaction at $3.33 per share. On Apr 07 ’25, another insider, Leverone Jason A., who serves as the Chief Financial Officer of the company, sold 1,844 shares for $2.67 each. As a result, the insider received 4,925 and left with 13,209 shares of the company.
Stock Price History:
Over the past 52 weeks, OKUR has reached a high of $20.00, while it has fallen to a 52-week low of $1.83. The 50-Day Moving Average of the stock is -48.90%, while the 200-Day Moving Average is calculated to be -82.19%.
Shares Statistics:
A total of 12.76M shares are outstanding, with a floating share count of 8.60M. Insiders hold about 36.32% of the company’s shares, while institutions hold 61.70% stake in the company.
Earnings Estimates
As of right now, 4 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$1.29, with high estimates of -$1.25 and low estimates of -$1.36.
Analysts are recommending an EPS of between -$4.43 and -$4.75 for the fiscal current year, implying an average EPS of -$4.66. EPS for the following year is -$3.44, with 4.0 analysts recommending between -$2.49 and -$4.2.
